APICO is still being established, while aiming at setting up a factory for intravenous solutions in addition to producing and marketing all kinds of intravenous solutions. APICO's vision is in concordance with the strategy, objectives and goals of ACDIMA represented in supporting the pharmaceutical industry in the Arab World while concentrating on diversification and covering all therapeutic categories and segments. APICO's capital is LYD 1 Million, of which ACDIMA owns 49%.